問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Find Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
Principal Investigator
李日翔
下載
2022-04-01 - 2026-03-31
Condition/Disease
Test Drug
Participate Sites8Sites
Recruiting8Sites
2022-11-01 - 2030-12-31
Not yet recruiting7Sites
Recruiting1Sites
2022-12-01 - 2026-06-30
Participate Sites7Sites
Recruiting7Sites
2022-04-01 - 2028-09-30
NSCLS
Telisotuzumab Vedotin (ABBV-399)
2021-02-06 - 2026-12-31
Participate Sites4Sites
Terminated4Sites
2021-09-22 - 2033-12-31
Participate Sites14Sites
Recruiting14Sites
2023-12-31 - 2026-03-18
xxxxxx
2023-08-01 - 2036-12-31
2023-01-01 - 2026-12-31
Recruiting2Sites
Terminated2Sites
2023-05-29 - 2027-01-31
Participate Sites3Sites
Recruiting3Sites
全部
